12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Optimer sales and marketing update

Optimer will implement a hospital contracting initiative to reduce the cost of Dificid fidaxomicin for inpatients in acute care hospitals. Optimer hopes the program will address the cost barrier to prescribing Dificid and possibly expand the general use in the retail market. Details on the strategy will be announced at a conference...

Read the full 249 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >